Kerala Ayurveda Ltd.
| BSE: 530163 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE817B01025 |
| BSE 14:17 | 12 Aug | 74.90 |
1.00 (1.35%) |
OPEN
75.00 |
HIGH
77.40 |
LOW
71.20 |
| NSE 05:30 | 01 Jan | Kerala Ayurveda Ltd |
| OPEN | 75.00 |
| PREVIOUS CLOSE | 73.90 |
| VOLUME | 1089 |
| 52-Week high | 86.05 |
| 52-Week low | 53.25 |
| P/E | 89.17 |
| Mkt Cap.(Rs cr) | 79 |
| Buy Price | 73.25 |
| Buy Qty | 10.00 |
| Sell Price | 75.00 |
| Sell Qty | 1.00 |
Kerala Ayurveda Ltd. (KERALAAYURVEDA) - Market Capital
Market Cap
| COMPANY | LATEST(Rs) | CHG(%) | 52 Wk High | 52 Wk Low | MKT-CAP (RS CR) |
| Sun Pharma.Inds. | 912.00 | -0.87 | 966.90 | 733.95 | 218816.15 |
| Divi's Lab. | 3733.85 | -5.42 | 5425.00 | 3365.10 | 99115.05 |
| Cipla | 1027.65 | -1.04 | 1083.15 | 850.00 | 82931.35 |
| Dr Reddy's Labs | 4283.50 | 0.62 | 5078.80 | 3655.00 | 71294.58 |
| Apollo Hospitals | 4300.00 | -3.03 | 5930.70 | 3365.90 | 61825.40 |
| Torrent Pharma. | 1535.00 | -0.02 | 1652.23 | 1242.50 | 51950.54 |
| Piramal Enterp. | 1920.10 | 0.73 | 3013.00 | 1561.00 | 45823.19 |
| Abbott India | 18825.25 | -0.62 | 23902.30 | 15525.00 | 40003.66 |
| Zydus Lifesci. | 385.10 | 0.88 | 577.35 | 319.40 | 39422.69 |
| Gland Pharma | 2352.00 | 0.19 | 4350.00 | 2180.10 | 38737.44 |
| Biocon | 311.15 | -1.46 | 410.50 | 305.00 | 37356.67 |
| Alkem Lab | 2974.35 | 0.00 | 4067.70 | 2835.00 | 35558.35 |
| Max Healthcare | 363.25 | -2.29 | 472.60 | 291.70 | 35221.81 |
| Aurobindo Pharma | 591.80 | 2.84 | 887.90 | 503.40 | 34673.56 |
| Lupin | 684.05 | -0.85 | 1090.60 | 583.05 | 31100.33 |
| Laurus Labs | 566.00 | 0.17 | 723.55 | 433.20 | 30414.01 |
| Glaxosmi. Pharma | 1441.25 | -0.07 | 1917.00 | 1372.80 | 24416.22 |
| Ipca Labs. | 931.70 | -8.25 | 1383.55 | 831.40 | 23637.23 |
| Syngene Intl. | 588.75 | 1.19 | 686.00 | 508.10 | 23634.19 |
| Fortis Health. | 289.00 | 6.78 | 313.80 | 219.80 | 21818.34 |
Quick Links for Kerala Ayurveda:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
